Search | IOVS | ARVO Journals

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2007

Ocular Toxicity of Intravitreous Adalimumab (Humira) in the Rabbit

H. M. Kwong, Jr.; R. P. A. Manzano; G. A. Peyman; P. E. Carvounis; P. Chévez-Barrios; M. Kivilcim; P. Khan

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):79. doi:

ARVO Annual Meeting Abstract May 2007

The Inhibition of Corneal Neovascularization With Single Dose Topical Applications of Combinations of Triamcinolone Acetonide, Low Molecular Weight Heparin and Doxicicline in an Experimental Model

M. D. Conway; M. Kivilcim; G. Peyman; A. A. Kazi

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1702. doi:

ARVO Annual Meeting Abstract May 2007

Inhibition of Corneal Angiogenesis by 11-Deoxycortisol and Aldosterone

M. Kivilcim; G. A. Peyman; R. P. A. Manzano; M. Caro Magdaleno

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1712. doi:

ARVO Annual Meeting Abstract May 2006

Inhibition of Corneal Angiogenesis by Fludrocortisone Acetate and Triamcinolone Acetonide in Rat Model

C.M. Jermak; M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1622. doi:

ARVO Annual Meeting Abstract May 2006

Inhibition of Corneal Neovascularization by Ascorbic Acid in Rat Model

G.A. Peyman; M. Kivilcim; J.T. Dellacroce; A. Munoz Morales

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1634. doi:

ARVO Annual Meeting Abstract May 2006

Inhibition of Experimental Angiogenesis of Cornea by Bevacizumab

M. Ren; R.P. A. Manzano; G.A. Peyman; P. Khan; P. Carvounis; M. Kivilcim

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1638. doi:

ARVO Annual Meeting Abstract May 2006

Inhibition of Experimental Corneal Neovascularization by Diclofenac, Ketorolac, and Etanercept

M.D. Conway; M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1639. doi:

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of Rapamycin

R.P. A. Manzano; G.A. Peyman; P. Khan; M. Kivilcim; J. Heffez

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4248. doi:

ARVO Annual Meeting Abstract May 2006

Evaluation of the Retinal Toxicity of Fludrocortisone Acetate After Intravitreal Injection

M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4281. doi:

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of High–Dose Etanercept

A. Munoz Morales; M. Kivilcim; G.A. Peyman; A.A. Kazi; J.T. Dellacroce; R. Ghabrial

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4293. doi:

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of Infliximab

A.A. Kazi; M. Kivilcim; G.A. Peyman; P. Khan; L. Trost

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4298. doi:

ARVO Annual Meeting Abstract May 2006

Effect of Intravitreally Injected Povidone–Iodine on Staphylococcus epidermidis in Rabbit Eyes

L.W. Trost; M. Kivilcim; G.A. Peyman; A. Munoz Morales

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5277. doi:

ARVO Annual Meeting Abstract May 2005

The Effect of Combinations of Flurbiprofen, Low Molecular Weight Heparin, and Doxycycline on the Inhibition of Corneal Neovascularization

A.A. Kazi; G.A. Peyman; M.R. Esfahani; E. Aydin; M. Kivilcim; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4478. doi:

ARVO Annual Meeting Abstract May 2005

Combination of Triamcinolone Acetonide With Low Molecular Weight Heparin and Doxycycline in Inhibition of Experimental Corneal Angiogenesis

M. Kivilcim; E. Aydin; G.A. Peyman; M. Riazi Esfahani; A.A. Kazi; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4479. doi:

ARVO Annual Meeting Abstract May 2005

Intravitreal Toxicity of Povidone–Iodine in Rabbit Eyes

L.W. Trost; M. Kivilcim; G.A. Peyman; E. Aydin; A.A. Kazi

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5566. doi:

Advertisement